title: Partial graft recovery following eradication of hepatitis E virus infection after successful islet allograft transplantation.
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Vantyghem
authors.forename: Philippe
authors.initials: P
authors.lastname: Mathurin
authors.forename: Didier
authors.initials: D
authors.lastname: Hober
authors.forename: Laurence
authors.initials: L
authors.lastname: Bocket
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Balavoine
authors.forename: Myriam
authors.initials: M
authors.lastname: Lazrek
authors.forename: Sébastien
authors.initials: S
authors.lastname: Dharancy
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Leteurtre
authors.forename: Julie
authors.initials: J
authors.lastname: Kerr-Conte
authors.forename: François
authors.initials: F
authors.lastname: Pattou
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D006442:Glycated Hemoglobin / Q000378:metabolism; D016751:Hepatitis E / Q000188:drug therapy*; D016752:Hepatitis E virus; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007515:Islets of Langerhans / Q000502:physiology*; D016381:Islets of Langerhans Transplantation; D008099:Liver / Q000201:enzymology; D008103:Liver Cirrhosis / Q000209:etiology; D020123:Sirolimus / Q000627:therapeutic use
chemical_list: D006442:Glycated Hemoglobin; D020123:Sirolimus; C517652:hemoglobin A1c protein, human